Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]
News [7011]
Articles [265]
Editorials [8]
Conferences [213]
elearning [41]
Epirubicin and cyclophosphamide before docetaxel in early breast cancer
Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark
Epirubicin and cyclophosphamide before docetaxel in early breast cancer ( Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark )
14 Dec 2016
Matched mutations and long term letrozole for breast cancer
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA
Matched mutations and long term letrozole for breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA )
14 Dec 2016
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer
Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA
neoMONARCH: CDK inhibition for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
13 Dec 2016
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer
Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )
13 Dec 2016
No benefit for adjuvant ibandronate at 3 years in early breast cancer
Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands
No benefit for adjuvant ibandronate at 3 years in early breast cancer ( Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands )
13 Dec 2016
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer
Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA
PARP inhibitory velaparib trialled in BRCA1/2 breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )
13 Dec 2016
Matched mutations in the progression of metastatic breast cancer
Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA
Matched mutations in the progression of metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )
13 Dec 2016
Comparison between standard and reduced volume radiotherapy in bladder...
Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt
Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients ( Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt )
13 Dec 2016
Breast cancer screening in the Philippines
Kara Alikpala - ICanServe Foundation, Manila, Philippines
Breast cancer screening in the Philippines ( Kara Alikpala - ICanServe Foundation, Manila, Philippines )
12 Dec 2016
PD-1 therapy with eribulin for triple negative MBC
Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA
PD-1 therapy with eribulin for triple negative MBC ( Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA )
9 Dec 2016
Women experiencing menopause symptoms less likely to adhere to medication
Dr Samuel Smith - University of Leeds, Leeds, UK
Women experiencing menopause symptoms less likely to adhere to medication ( Dr Samuel Smith - University of Leeds, Leeds, UK )
9 Dec 2016
Breast cancer mortality declining globally
Dr Cécile Pizot - International Prevention Research Institute, Lyon, France
Breast cancer mortality declining globally ( Dr Cécile Pizot - International Prevention Research Institute, Lyon, France )
9 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation